Europe Cardiovascular Needle Market

Market Introduction

The cardiovascular needles are used during a number of cardiovascular surgeries such as open-heart surgery, cardiac valve procedures, heart transplant, coronary artery bypass graft surgery, and many more surgeries need surgical needles. These cardiovascular needles are of two types: single use or eyeless needles and multiple use or eyed needles. Cardiovascular needles are manufactured from new stainless-steel alloys containing high concentrations of nickel, Surgalloy and Ethalloy.

 Thus, the increasing prevalence of cardiovascular diseases are expected to create a significant demand for cardiovascular needle in the coming years, which is further anticipated to drive the cardiovascular needle market.

Cardiac surgery across Europe is being set back as a result of the ongoing coronavirus. Operations are being postponed, treatment delayed, and critical care staff have been redeployed to cope with the impact of the Covid-19 epidemic on health services. While evidence illustrates a significant fall in heart surgery procedures in the United States and in the UK. In England, the charity the British Heart Foundation has monitored the situation and found that around 371,000 heart operations and procedures were performed in 2020, down 22 per cent from 2019 when more than 473,000 were carried out. Operations such as coronary bypass and heart valve surgery fell from 37,000 cases to around 25,000 by the end of November 2020, compared with 2019, while procedures such as fitting stents to open blocked arteries also fell. Meanwhile, research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons showed that in the United States Covid-19 resulted in a 53% decrease nationwide in all adult cardiac surgery. Data from Public Health England show there have been at least 5,700 excess deaths from heart diseases and stroke since the pandemic began. Delays to heart operations and procedures are likely contributing to more deaths than expected.

Europe Cardiovascular Needle Strategic Insights

Strategic insights for the Europe Cardiovascular Needle provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Cardiovascular Needle Report Scope

Europe Cardiovascular Needle Regional Insights

The geographic scope of the Europe Cardiovascular Needle refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Cardiovascular needle market in Europe is expected to grow from US$ 24,408.5 thousands in 2021 to US$ 39,261.2 thousands by 2028; it is estimated to grow at a CAGR of 7.0% from 2021 to 2028. The prevalence of cardiovascular conditions is significantly rising in developing countries due to shift in lifestyle, and the modernization of commercial, industrial, and residential infrastructure; the modernized facilities result in reduced physical activities. On the other hand, stress levels continue to rise among people. Thus, these factors are driving the prevalence of cardiovascular conditions in developing countries. Further, these countries are significantly developing their healthcare facilities and services and are heading toward technological advancements. As per the study Global Burden of Disease in the Lancet, ~10 deaths are associated with this disease, which is equivalent to ~6.4 million deaths. Thus, emerging countries provide significant opportunities for the cardiovascular needles market players; they can enter these untapped or less explored markets with cost-effective products during the forecast period.

Key Market Segments

In terms of type, the round-bodied needles segment accounted for the largest share of the Europe cardiovascular needle market in 2020. In terms of application, the open-heart surgery segment accounted for the largest share of the Europe cardiovascular needle market in 2020. In terms of usage, the single use segment accounted for the largest share of the Europe cardiovascular needle market in 2020. In terms of end user, the hospitals and clinics segment accounted for the largest share of the Europe cardiovascular needle market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the cardiovascular needle market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Ethicon (Johnson & Johnson Services, Inc.), MANI, INC., Barber of Sheffield, FSSB surgical needles GmbH, Medtronic, Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., CP Medical, and SMB Corporation of India.

Reasons to buy report

• To understand the Europe Cardiovascular needle market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe Cardiovascular needle market
• Efficiently plan M&A and partnership deals in Europe Cardiovascular needle market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe Cardiovascular needle market
• Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

Europe Cardiovascular Needle Market Segmentation    

By Application

• Open Heart Surgery
• Cardiac Valve Procedures

By Usage

• Single Use
• Multiple Uses

By End User

• Hospitals and Clinics
• Ambulatory Surgical Centres
• Cardiovascular Centres

By Country

• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Companies Mentioned

1. Ethicon (Johnson & Johnson Services, Inc.)              
2. MANI, INC              
3. Barber of Sheffield             
4. FSSB surgical needles GmbH          
5. Medtronic              
6. Teleflex Incorporated       
7. Meril Life Sciences Pvt. Ltd.             
8. CP Medical             
9. SMB Corporation of India